-transparent.png){kind=logo}
11 volunteers received 1 g ceftriaxone i.m. every 24 h for 5 consecutive days. Volunteers were selected on the basis of the "ceftriaxone inactivating capacity" of their faeces, which should be 250 mg/kg faeces. The effect of treatment on the aerobic oral and faecal flora was studied. In the oral flora a temporary suppression of the viridans streptococci occurred, which normalised already during treatment. More spectacular was the effect on the faecal flora: suppression of aerobic Gram-negative bacilli with overgrowth of yeasts and enterococci. Two weeks after treatment the results of the faecal cultures were almost the same as before treatment in most of the volunteers. One volunteer experienced severe diarrhoea, starting the day after completion of ceftriaxone treatment and lasting 2 days.
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
April 1986,
European journal of clinical microbiology,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
January 1985,
Infection,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
October 1988,
The Journal of antimicrobial chemotherapy,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
August 1990,
The Journal of antimicrobial chemotherapy,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
September 1988,
The Journal of antimicrobial chemotherapy,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
January 2001,
Mycoses,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
December 1987,
Pharmaceutisch weekblad. Scientific edition,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
September 1990,
Pathologie-biologie,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
January 1983,
Chemotherapy,
H G de Vries-Hospers, and
R H Tonk, and
D van der Waaij
June 1991,
Epidemiology and infection,
